
Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : CB307
Therapeutic Area : Oncology
Study Phase : Phase I
Sponsor : Crescendo Biologics Ltd
Deal Size : Undisclosed
Deal Type : Agreement
Angle PLC, Crescendo Biologics Ink Clinical Services Contract
Details : Under the agreement, Crescendo will use ANGLE's recently launched Portrait Flex assay in its Phase 1 trial investigating the safety and efficacy of CB307, a first-in-class PSMA x CD137 half-life extended bispecific, for treating patients with PSMA positi...
Product Name : Undisclosed
Product Type : Antibody, Unconjugated
Upfront Cash : Undisclosed
April 13, 2023
Lead Product(s) : CB307
Therapeutic Area : Oncology
Highest Development Status : Phase I
Sponsor : Crescendo Biologics Ltd
Deal Size : Undisclosed
Deal Type : Agreement

Contact Us!